This online event will explore the challenges when working with Orphan Drugs and Rare Diseases, and the benefits from a development viewpoint. It will explore the benefits of early planning and engagement with the FDA, as well as looking into case studies on what has and has not been an effective strategy in Rare Disease trials.
With over 40 solution providers the virtual meeting will be a perfect platform to reconnect with current business partners, meet new vendors and discover which new technologies are being employed to improve your Rare Disease clinical trials.
At each virtual event we create a welcoming networking environment and an educational program packed with the latest case studies, techniques and providers to set your trial apart. The Arena team will bring some of the leading voices in Rare Disease who are best situated to answer your questions and provide you the insight you need to successfully run your trial.